Cargando…
Safety of repeated transplantations of neurotrophic factors-secreting human mesenchymal stromal stem cells
BACKGROUND: Therapies based on mesenchymal stem cells (MSC) have been shown to have potential benefit in several clinical studies. We have shown that, using a medium-based approach, MSC can be induced to secrete elevated levels of neurotropic factors, which have been shown to have protective effects...
Autores principales: | Gothelf, Yael, Abramov, Natalie, Harel, Adrian, Offen, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108239/ https://www.ncbi.nlm.nih.gov/pubmed/25097724 http://dx.doi.org/10.1186/2001-1326-3-21 |
Ejemplares similares
-
miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors
por: Gothelf, Yael, et al.
Publicado: (2017) -
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis
por: Cohen, Jeffrey A, et al.
Publicado: (2022) -
Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington's disease
por: Sadan, Ofer, et al.
Publicado: (2012) -
A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis
por: Cudkowicz, Merit E., et al.
Publicado: (2022) -
Hypoxia, a dynamic tool to amplify the gingival mesenchymal stem cells potential for neurotrophic factor secretion
por: Patil, Shankargouda, et al.
Publicado: (2022)